Trends & Forecasts

2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...

Sitting Down With... Vivek Sharma, CEO of Piramal Pharma Solutions.

The business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.

Can blockchain transform how we use, share, interact with and benefit from it.

Eva discovers that Gene's project management skills leave a lot to be desired...

A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

Collaboration seeks to use artificial intelligence to predict how patients will respond to immunotherapy.